PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsFever
MeSH D005334 - fever
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D001832:Body temperature changes
0 Companies
0 Drugs
Success rate
D005334: 
Fever
D005335:Fever of unknown origin
0 Companies
0 Drugs
Success rate
D018614:Sweating sickness
0 Companies
0 Drugs
Success rate
D000092582:Drug fever
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyAspirin, Methocarbamol Robaxisal  1982-01-01   
Acetaminophen, Codeine Phenaphen  1982-01-01   
AAIPharmaAcetaminophen, Propoxyphene Darvocet  1982-01-01   
Aspirin, Propoxyphene napsylate Darvon-n W/ Asa  1982-01-01   
Abbott BiotherapeuticsAspirin, Hydrocodone Vicoprin  1983-09-14   
Acetaminophen, Hydrocodone Vicodin  1982-01-01   
Ibuprofen Ibu  1989-12-18   
Ibuprofen Ibuprofen  1985-06-14   
AbbVieAcetaminophen, Hydrocodone Vicodin  1996-09-23   
Ibuprofen, Hydrocodone Vicoprofen  1997-09-23   
Able LaboratoriesAcetaminophen Acetaminophen  1995-02-27   
Acetaminophen, Codeine Acetaminophen Codeine  2002-08-01   
Acetaminophen, Caffeine, Butalbital Butalbital, Acetaminophen Caffeine  2001-07-23   
Acetaminophen, Caffeine, Codeine, Butalbital Butalbital, Acetaminophen, Caffeine Codeine  2003-08-21   
Acetaminophen, Hydrocodone Hydrocodone Acetaminophen  2002-10-23   
Acetaminophen, Propoxyphene napsylate Propoxyphene Napsylate Acetaminophen  2001-07-11   
ACI HealthcareAcetaminophen, Codeine Acetaminophen Codeine  1982-01-01   
AkornAcetaminophen, Codeine Acetaminophen Codeine  1996-04-26   
ALK-AbellóCiprofloxacin Otiprio 2029-04-21 2015-12-10   
Alkem LaboratoriesAcetaminophen, Tramadol Tramadol Acetaminophen  2012-03-30   
Ibuprofen Ibuprofen  2021-09-13   
Famotidine, Ibuprofen Ibuprofen Famotidine  2021-08-03   
1
2
3
4
5
6
...
18
>
Clinical Trials
Historical Success Rate
Phase 1
62%
13/21
Phase 2
32%
8/25
Phase 3
63%
26/41
Approved: 12Overall Success rate: 13%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Abbott Biotherapeutics
1
2
3
4
5
6
...
12
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use